Pulse

‘Kem Cho,’ Trump

| Updated on February 15, 2020 Published on February 15, 2020

US PresidentDonald Trump’s visit to India later this month (February 24-25) has the healthcare circle abuzz with anticipation and concern. With expectations of a trade deal from the visit, healthcare workers are apprehensive on whether safeguards involving intellectual property and patents could get watered down. The trigger for these concerns comes from constant criticism of the amended Indian Patents Act’s (2005) Section 3 (d), for instance, that prevents frivolous patenting and the monopoly that follows.

Similar concerns are also being expressed on medical technology, for instance, where the Indian government had taken strident steps to curb exorbitant margins on medical devices, only to slow down later.

Published on February 15, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.